Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$3.4M
Filings
59
Firms Hired
3
Active Period
1999–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Funding for the Public Health Social Services Emergency Fund (PHSSEF) - Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 10545
National Defense Authorization Act for Fiscal Year 2026
2026 · third_quarter · Firm: CGCN GROUP, LLC
S.1071 - National Defense Authorization Act for Fiscal Year 2026.
Client expense: — · Firm income: $50,000
Matched citations: S.1071
National Defense Authorization Act for Fiscal Year 2026
2026 · third_quarter · Firm: FUJIFILM HOLDINGS AMERICA CORPORATION
S.1071 - National Defense Authorization Act for Fiscal Year 2026
Client expense: $215,000 · Firm income: —
Matched citations: S.1071
Funding for the Public Health Social Services Emergency Fund (PHSSEF) - Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 10545
National Defense Authorization Act for Fiscal Year 2026
2026 · second_quarter · Firm: CGCN GROUP, LLC
S.1071 - National Defense Authorization Act for Fiscal Year 2026.
Client expense: — · Firm income: $50,000
Matched citations: S.1071
National Defense Authorization Act for Fiscal Year 2026
2026 · second_quarter · Firm: FUJIFILM HOLDINGS AMERICA CORPORATION
S.1071 - National Defense Authorization Act for Fiscal Year 2026
Client expense: $215,000 · Firm income: —
Matched citations: S.1071
Funding for the Public Health Social Services Emergency Fund (PHSSEF) - Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 10545
National Defense Authorization Act for Fiscal Year 2026
2026 · first_quarter · Firm: CGCN GROUP, LLC
S.1071 - National Defense Authorization Act for Fiscal Year 2026.
Client expense: — · Firm income: $50,000
Matched citations: S.1071
National Defense Authorization Act for Fiscal Year 2026
2026 · first_quarter · Firm: FUJIFILM HOLDINGS AMERICA CORPORATION
S.1071 - National Defense Authorization Act for Fiscal Year 2026
Client expense: $200,000 · Firm income: —
Matched citations: S.1071
Funding for the Public Health Social Services Emergency Fund (PHSSEF) - Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 10545
National Defense Authorization Act for Fiscal Year 2026
2025 · fourth_quarter · Firm: CGCN GROUP, LLC
S.1071 - National Defense Authorization Act for Fiscal Year 2026.
Client expense: — · Firm income: $50,000
Matched citations: S.1071
National Defense Authorization Act for Fiscal Year 2026
2025 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues related to Section 851 (prohibition on contracting with certain biotechnology providers) of the National Defense Authorization Act for Fiscal Year 2026 (P.L. 119-60); Issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026 (BIOSECURE Act).
Client expense: — · Firm income: $110,000
Matched citations: S. 2296
National Defense Authorization Act for Fiscal Year 2026
2025 · fourth_quarter · Firm: FUJIFILM HOLDINGS AMERICA CORPORATION
S.1071 - National Defense Authorization Act for Fiscal Year 2026
Client expense: $205,000 · Firm income: —
Matched citations: S.1071
Funding for the Public Health Social Services Emergency Fund (PHSSEF) - Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 10545
National Defense Authorization Act for Fiscal Year 2026
2025 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues related to support for domestic pharmaceutical manufacturing and the BIOSECURE Act; Issues related to S.Amdt.3236 to National Defense Authorization Act for Fiscal Year 2026 (S. 2296).
Client expense: — · Firm income: $110,000
Matched citations: S. 2296
Funding for the Public Health Social Services Emergency Fund (PHSSEF) - Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 10545
Funding for the Public Health Social Services Emergency Fund (PHSSEF) - Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 10545
Issues regarding support for domestic pharmaceutical manufacturing and the BIOSECURE Act (H.R. 8333 - BIOSECURE Act (118th Congress); S.3558 - Prohibiting Foreign Access to American Genetic Information Act of 2024 (118th Congress)).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 8333
Prohibiting Foreign Access to American Genetic Information Act of 2024
2025 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues regarding support for domestic pharmaceutical manufacturing and the BIOSECURE Act (H.R. 8333 - BIOSECURE Act (118th Congress); S.3558 - Prohibiting Foreign Access to American Genetic Information Act of 2024 (118th Congress)).
Client expense: — · Firm income: $60,000
Matched citations: S.3558
BIOSECURE Act
2024 · fourth_quarter · Firm: FUJIFILM HOLDINGS AMERICA CORPORATION
Domestic manufacturing, medicare coverage and reimbursement for ultrasound BioSecure Act - H.R.8333/S. 3558 Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Biomedical Advanced Research and Development Authority (BARDA) Reauthorization of Pandemic and All- Hazards Preparedness and Advancing Innovation Act; International trade issues
Client expense: $225,000 · Firm income: —
Matched citations: H.R.8333
Prohibiting Foreign Access to American Genetic Information Act of 2024
2024 · fourth_quarter · Firm: FUJIFILM HOLDINGS AMERICA CORPORATION
Domestic manufacturing, medicare coverage and reimbursement for ultrasound BioSecure Act - H.R.8333/S. 3558 Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Biomedical Advanced Research and Development Authority (BARDA) Reauthorization of Pandemic and All- Hazards Preparedness and Advancing Innovation Act; International trade issues
Client expense: $225,000 · Firm income: —
Matched citations: S. 3558
Issues related to domestic pharmaceutical manufacturing; S.3558 - Prohibiting Foreign Access to American Genetic Information Act of 2024; H.R. 8333 - BIOSECURE Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 8333
Prohibiting Foreign Access to American Genetic Information Act of 2024
2024 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues related to domestic pharmaceutical manufacturing; S.3558 - Prohibiting Foreign Access to American Genetic Information Act of 2024; H.R. 8333 - BIOSECURE Act.
Client expense: — · Firm income: $60,000
Matched citations: S.3558
Funding for the Public Health Social Services Emergency Fund (PHSSEF) - Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 10545
Support for biopharmaceutical manufacturing in the U.S.; Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; BioSecure Act - H.R.8333/S. 3558
Client expense: — · Firm income: $50,000
Matched citations: H.R.8333
Source: Senate LDA